5 completed, 3 unknown, 2 recruiting, 2 terminated. 4 Not applicable, 2 Phase 1, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 1, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Vaginal Candidiasis: new trials by email Literature Review of Vaginal Candidiasis trials Research Report on Vaginal Candidiasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes Non-interventional study - Vulvovaginitis, Candidal, Vulvovaginal Candidiasis | Recruiting | GlaxoSmithKline | 100 | 2025-11-12 | 2026-09-23 | |
| Multi-Gyn FemiTotal for the Treatment and Prevention of Vulvovaginal Candidiasis Symptoms and Bacterial Vaginosis Multi-Gyn FemiTotal - Bacterial Vaginosis, Vaginal Candidiasis | Not applicable | Recruiting | Karo Pharma AB | 80 | 2025-10-22 | 2026-10-02 |
| Postbiotic as Adjunct Treatment for Vaginal Candidiasis Postbiotic, Placebo - Vaginal Candidiasis | Phase 2 / Phase 3 | Completed | Min-Tze LIONG | 99 | 2024-06-02 | 2026-07-07 |
| Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp Ibrexafungerp - Vulvovaginal Candidiasis, Candida Infection | Phase 1 | Completed | Scynexis, Inc. | 5 | 2023-07-12 | 2025-08-08 |
| Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis VagiVitalAC - Vaginal Candidiasis, Vulvovaginal Candidiasis | Not applicable | Unknown | PepTonic Medical AB | 126 | 2021-09-01 | 2021-09-23 |
| Implementation of a Minor Ailment Service in Community Pharmacy Practice Minor ailment service - Acne, Bites | Not applicable | Completed | Universidad de Granada | 20987 | 2020-10-01 | 2023-12-07 |
| Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis Ketoconazole, Terconazole - Vaginal Candidiasis | Phase 3 | Unknown | Assiut University | 69 | 2018-04-01 | 2018-03-22 |
| Women's Improvement of Sexual Health (WISH) Demonstration Project Urogenital infection point-of-care tests - Sexually Transmitted Disease, Bacterial Vaginosis | Completed | Janneke van de Wijgert | 705 | 2016-07-05 | 2019-09-11 | |
| Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women Microbiome, Antibiotic-Induced VVC | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 13 | 2013-07-30 | 2019-09-12 | |
| Observational Program Neo-Penotran® Forte Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276) - Vaginal Candidiasis, Bacterial Vaginosis | Completed | Bayer | 13024 | 2010-10-01 | 2016-07-25 | |
| Prevention of Recurrent Vulvovaginal Candidiasis With Lactibiane Candisis 5M® Lactibiane candisis 5M - Vaginal Candidiasis | Not applicable | Terminated | PiLeJe | 134 | 2009-06-01 | 2021-04-20 |
| Use of Oral Probiotics as an Adjunctive Therapy to Fluconazole in the Treatment of Yeast Vaginitis Probiotics (Natural product), Probiotics (L. rhamnosus GR-1 and L. reuteri RC-14) - Vaginal Candidiasis | Phase 1 | Unknown | Faith Mediplex | 100 | 2007-05-01 | 2007-05-30 |
Candidiasis, Vulvovaginal (12) · Vaginosis, Bacterial (3) · Candidiasis (2) · Candidiasis, Oral (2) · Acne Vulgaris (1) · Bites and Stings (1) · Burns (1) · Common Cold (1) · Constipation (1) · Cough (1) · Dermatitis (1) · Diarrhea (1) · Dry Eye Syndromes (1) · Dysmenorrhea (1) · Exanthema (1)
Bacterial Infections and Mycoses (12) · Female Urogenital Diseases (12) · Female Urogenital Diseases and Pregnancy Complications (12) · Genital Diseases (12) · Genital Diseases, Female (12) · Infections (12) · Urogenital Diseases (12) · Vaginal Diseases (12) · Vaginitis (12) · Vulvar Diseases (12) · Vulvitis (12) · Mycoses (11) · Vulvovaginitis (11) · Candidiasis (10) · Bacterial Infections (3)
Biological Products (1) · Ketoconazole (1) · Metronidazole (1) · Miconazole (1) · Probiotics (1) · ibrexafungerp (1) · terconazole (1)
Assiut University (1) · Bayer (1) · Faith Mediplex (1) · GlaxoSmithKline (1) · Janneke van de Wijgert (1) · Karo Pharma AB (1) · Min-Tze LIONG (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · PepTonic Medical AB (1) · PiLeJe (1) · Scynexis, Inc. (1) · Universidad de Granada (1)
India (2) · United States (2) · France (1) · Kazakhstan (1) · Malaysia (1) · Mauritius (1) · Nigeria (1) · Rwanda (1) · Spain (1) · Sweden (1)
Aino Fianu Jonasson, MD, PhD (1) · Janneke van de Wijgert, MD PhD MPH (1) · Michail S Lionakis, M.D. (1) · Shalom I Benrimoj, PhD (1) · Sumita Bhatia, MD (1)